Bruce J. Seeley

2019 - CTI BioPharma

In 2019, Bruce J. Seeley earned a total compensation of $859.5K as Executive Vice President, Chief Operating Officer at CTI BioPharma, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$185,812
Option Awards$244,640
Salary$420,629
Other$8,400
Total$859,481

Seeley received $420.6K in salary, accounting for 49% of the total pay in 2019.

Seeley also received $185.8K in non-equity incentive plan, $244.6K in option awards and $8.4K in other compensation.

Rankings

In 2019, Bruce J. Seeley's compensation ranked 9,938th out of 13,971 executives tracked by ExecPay. In other words, Seeley earned more than 28.9% of executives.

ClassificationRankingPercentile
All
9,938
out of 13,971
29th
Division
Manufacturing
4,012
out of 5,695
30th
Major group
Chemicals And Allied Products
1,523
out of 2,194
31st
Industry group
Drugs
1,302
out of 1,880
31st
Industry
Pharmaceutical Preparations
967
out of 1,392
31st
Source: SEC filing on April 23, 2020.

Seeley's colleagues

We found two more compensation records of executives who worked with Bruce J. Seeley at CTI BioPharma in 2019.

2019

Adam Craig

CTI BioPharma

Chief Executive Officer

2019

David Kirske

CTI BioPharma

Chief Financial Officer

News

You may also like